INNOGENE Co.,Ltd. (KOSDAQ:344860)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,571.00
-10.00 (-0.63%)
At close: Apr 29, 2026

INNOGENE Revenue

In the year 2025, INNOGENE had annual revenue of 8.21B KRW, down -8.17%. INNOGENE had revenue of 2.41B in the quarter ending December 31, 2025, with 17.50% growth.

Revenue
8.21B
Revenue Growth
-8.17%
P/S Ratio
2.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.90B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20258.21B-731.15M-8.17%
Dec 31, 20248.94B-1.16B-11.45%
Dec 31, 202310.10B961.65M10.52%
Dec 31, 20229.14B-245.63M-2.62%
Dec 31, 20219.39B3.74B66.29%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medience 48.77B
Nord Mason 21.26B
Ha U Dong Chun 1.89B
KMPHARMACEUTICAL 15.99B
Csa Cosmic 27.93B
Outin Futures 42.39B
SR biotek 1.62B
Bonne 46.01B
Revenue Rankings